Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

Citation

Hew, M, Gillman, A, Sutherland, M et al 2016, 'Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria', Clinical and Experimental Allergy, vol. 46, no. 11, pp. 1407-1415.

Year

2016

Fields of Research

  • Respiratory Diseases
  • Allergy

Updated:  29 February 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers